A Dashboard to Support Decision-Making Processes in Learning Ecosystems

There are software solutions to solve most of the problems related to information management in any company or institutions, but still, there is a problem for transforming information into knowledge. Technological ecosystems emerge as a solution to combine existing tools and human resources to solve different problems of knowledge management. In particular, when the ecosystem is focused on learning processes associated with knowledge are named learning ecosystems. The learning ecosystem metamodel defined in previous works solves several problems related to the definition and implementation of these solutions. However, there are still challenges associated with improving the analysis and visualization of information as a way to discover knowledge and support decision making processes. On the other hand, there is a metamodel proposal to define customized dashboards for supporting decision-making processes. This proposal aims to integrate both metamodels as a way to improve the definition of learning ecosystems

Generating Dashboards Using Fine-Grained Components: A Case Study for a PhD Programme

Developing dashboards is a complex domain, especially when several stakeholders are involved; while some users could demand certain indicators, other users could demand specific visualizations or design features. Creating individual dashboards for each potential need would consume several resources and time, being an unfeasible approach. Also, user requirements must be thoroughly analyzed to understand their goals regarding the data to be explored, and other characteristics that could affect their user experience. All these necessities ask for a paradigm to foster reusability not only at development level but also at knowledge level. Some methodologies, like the Software Product Line paradigm, leverage domain knowledge and apply it to create a series of assets that can be composed, parameterized, or combined to obtain fully functional systems. This work presents an application of the SPL paradigm to the domain of information dashboards, with the goal of reducing their development time and increasing their effectiveness and user experience. Different dashboard configurations have been suggested to test the proposed approach in the context of the Education in the Knowledge Society PhD programme of the University of Salamanca

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

IMPORTANCE: Secretory phospholipase A2(sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE: To determine the effects of sPLA2inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS: Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES: The primary efficacy measurewas a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS: At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95%CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95%CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE: In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01130246. Copyright 2014 American Medical Association. All rights reserved

The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria

Perilipin 5 (PLIN5/OXPAT) is a lipid droplet (LD) coat protein mainly present in tissues with a high fat-oxidative capacity, suggesting a role for PLIN5 in facilitating fatty acid oxidation. Here, we investigated the role of PLIN5 in fat oxidation in skeletal muscle. In human skeletal muscle, we observed that PLIN5 (but not PLIN2) protein content correlated tightly with OXPHOS content and in rat muscle PLIN5 content correlated with mitochondrial respiration rates on a lipid-derived substrate. This prompted us to examine PLIN5 protein expression in skeletal muscle mitochondria by means of immunogold electron microscopy and Western blots in isolated mitochondria. These data show that PLIN5, in contrast to PLIN2, not only localizes to LD but also to mitochondria, possibly facilitating fatty acid oxidation. Unilateral overexpression of PLIN5 in rat anterior tibialis muscle augmented myocellular fat storage without increasing mitochondrial density as indicated by the lack of change in protein content of five components of the OXPHOS system. Mitochondria isolated from PLIN5 overexpressing muscles did not possess increased fatty acid respiration. Interestingly though, 14C-palmitate oxidation assays in muscle homogenates from PLIN5 overexpressing muscles revealed a 44.8% (P = 0.05) increase in complete fatty acid oxidation. Thus, in mitochondrial isolations devoid of LD, PLIN5 does not augment fat oxidation, while in homogenates containing PLIN5-coated LD, fat oxidation is higher upon PLIN5 overexpression. The presence of PLIN5 in mitochondria helps to understand why PLIN5, in contrast to PLIN2, is of specific importance in fat oxidative tissues. Our data suggests involvement of PLIN5 in directing fatty acids from the LD to mitochondrial fatty acid oxidation

HLA class II DNA typing in a large series of European patients with systemic lupus erythematosus: correlations with clinical and autoantibody subsets

We conducted this study to determine the HLA class II allele associations in a large cohort of patients of homogeneous ethnic derivation with systemic lupus erythematosus (SLE). The large sample size allowed us to stratify patients according to their clinical and serologic characteristics. We studied 577 European Caucasian patients with SLE. Antinuclear antibodies (Hep-2 cells), anti-dsDNA antibodies (Crithidia luciliae), and antibodies to extractable nuclear antigens Ro (SS-A), La (SS-B), U1-RNP, Sm, Jo1, SCL70, and PCNA, were detected in all patients. Molecular typing of HLA-DRB1, DRB3, DQA1, and DQB1 loci was performed by the polymerase chain reaction-sequence specific oligonucleotide probes (PCR-SSOP) method. We found a significantly increased frequency of DRB1*03, DRB1*15, DRB1*16, DQA1*0102, DQB1*0502, DQB1*0602, DQB1*0201, DQB1*0303, and DQB1*0304 in lupus patients as compared with healthy controls. In addition, DRB1*03 was associated with anti-Ro, anti-La, pleuritis, and involvement of lung, kidney, and central nervous system. DRB1*15 and DQB1*0602 were associated with anti-dsDNA antibodies; DQB1*0201 with anti-Ro and anti-La, leukopenia, digital skin vasculitis, and pleuritis; and DQB1*0502 was associated with anti-Ro, renal involvement, discoid lupus, and livedo reticularis. In conclusion, our study shows some new HLA clinical and serologic associations in SLE and further confirms that the role of MHC genes is mainly to predispose to particular serologic and clinical manifestations of this disease

The hydrological response of soil surfaces to rainfall as affected by cover and position of rock fragments in the top layer

Rainfall experiments have been conducted in the laboratory in order to assess the hydrological response of top soils very susceptible to surface sealing and containing rock fragments in different positions with respect to the soil surface. For a given cover level, rock fragment position in the top soil has an ambivalent effect on water intake and runoff generation. Compared to a bare soil surface rock fragments increase water intake rates as well as time of runoff concentration and decrease runoff volume if they rest on the soil surface. For the same cover level, rock fragments reduce infiltration rate and enhance runoff generation if they are well embedded in the top layer. The effects of rock fragment position on infiltration rate and runoff generation are proportional to cover percentage. Micromorphological analysis and measurements of the saturated hydraulic conductivity of bare top soils and of the top layer underneath rock fragments resting on the soil surface reveal significant differences supporting the mechanism proposed by Poesen (1986): i.e. runoff generated as rock flow or as Horton overland flow can (partly) infiltrate into the unsealed soil surface under the rock fragments, provided that they are not completely embedded in the top layer. Hence, rock fragment position, beside other rock fragment properties, should be taken into account when assessing the hydrological response of soils susceptible to surface sealing and containing rock fragments in their surface layers. A simple model, based on the proportions of bare soil surface, soil surface occupied by embedded rock fragments, and soil surface covered with rock fragments resting on the soil surface, describes the runoff coefficient data relatively well. Copyright © 1990 John Wiley & Sons, Ltdstatus: publishe

A realistic large-signal microwave PHEMT transistors model for SPICE

A comprehensive large-signal HEMT model that provides a realistic description of measured characteristics over all operating regions for different PHEMTs is presented. The model was previously tested in harmonic-balance based simulators [1] and for the first time it has been implemented inside the time domain SPICE simulator. In order to do that, a new set of routines and libraries has been developed. The procedure introduced here can be extended to properly simulate other kind of devices described in terms of equivalent circuits. DC and scattering simulation results show very good agreement with the experimental measurements

Chronic non-cancer pain in children: we have a problem, but also solutions

Chronic non-cancer pain in children and adolescents has been described as “a modern public health disaster” that has generated significant medical and economic burdens within society. Seen as a disease in its own right, chronic pain has short and long-term consequences that impact not only the patient’s health but also that of friends and families, due to significant parenting stress and disruptions in family life and structure. The evidence supporting pharmacological treatments and interventional procedures is limited, and no single strategy has been shown to be completely effective in children with chronic non-cancer pain. Therefore, considering the multifactorial nature of chronic pain, these patients should be treated with a multidisciplinary, balanced approach that seeks a primary outcome of improved functioning rather than of pain reduction. Using a bio-psycho-social approach, a multidisciplinary team, including a physiotherapist, nurse, social worker, psychologist, and physician, has been effective in achieving this outcome of improved functioning in children and adolescents with chronic pain. In this review, we discuss the impact, associated conditions, and evolution of chronic pain, along with the crucial role of every member of a multidisciplinary chronic pain clinic involved in the care of the children and adolescents with chronic non-cancer pain